Biomedical Computer Technologies NyRt. (FRA:BCT) EBIT : €-1.39 Mil (TTM As of Jun. 2021)

View and export this data going back to . Start your Free Trial

What is Biomedical Computer Technologies NyRt. EBIT?

Biomedical Computer Technologies NyRt.'s earnings before interest and taxes (EBIT) for the six months ended in Jun. 2021 was €-0.71 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Jun. 2021 was €-1.39 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Biomedical Computer Technologies NyRt.'s annualized ROC % for the quarter that ended in Jun. 2021 was -12.01%. Biomedical Computer Technologies NyRt.'s annualized ROC (Joel Greenblatt) % for the quarter that ended in Jun. 2021 was -15.96%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. Biomedical Computer Technologies NyRt.'s Earnings Yield (Joel Greenblatt) % for the quarter that ended in Jun. 2021 was -24.70%.

Biomedical Computer Technologies NyRt. EBIT Historical Data

The historical data trend for Biomedical Computer Technologies NyRt.'s EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biomedical Computer Technologies NyRt. EBIT Chart

Biomedical Computer Technologies NyRt. Annual Data

Trend

Dec11

Dec12

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

EBIT

Get a 7-Day Free Trial

-0.02

-0.03

0.29

-0.39

Biomedical Computer Technologies NyRt. Semi-Annual Data
	Dec11	Jun12	Dec12	Jun13	Dec13	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21
EBIT	Get a 7-Day Free Trial															-0.14	0.14	0.29	-0.68	-0.71

Competitive Comparison of Biomedical Computer Technologies NyRt.'s EBIT

For the Specialty Industrial Machinery subindustry, Biomedical Computer Technologies NyRt.'s EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Biomedical Computer Technologies NyRt.'s EV-to-EBIT Distribution in the Industrial Products Industry

For the Industrial Products industry and Industrials sector, Biomedical Computer Technologies NyRt.'s EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Biomedical Computer Technologies NyRt.'s EV-to-EBIT falls into.

Biomedical Computer Technologies NyRt. EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Jun. 2021 adds up the semi-annually data reported by the company within the most recent 12 months, which was €-1.39 Mil.

Biomedical Computer Technologies NyRt. (FRA:BCT) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Biomedical Computer Technologies NyRt.'s annualized ROC % for the quarter that ended in Jun. 2021 is calculated as:

	ROC % (Q: Jun. 2021 )
=	NOPAT	/	Average Invested Capital
=	Operating Income * ( 1 - Tax Rate % )	/	( (Invested Capital (Q: Dec. 2020 )	+	Invested Capital (Q: Jun. 2021 ))	/ count )
=	-1.412 * ( 1 - 0.15% )	/	( (12.377	+	11.098)	/ 2 )
=	-1.409882	/	11.7375
=	-12.01 %

where

	Invested Capital		(Q: Dec. 2020 )
=	Total Assets	-	Accounts Payable & Accrued Expense	-	Excess Cash
=	Total Assets	-	Accounts Payable & Accrued Expense	-	( Cash, Cash Equivalents, Marketable Securities	-	max(0, Total Current Liabilities	-	Total Current Assets	+	Cash, Cash Equivalents, Marketable Securities	))
=	15.505	-	2.871	-	( 0.257	-	max(0, 4.527	-	10.163	+	0.257	))
=	12.377

	Invested Capital		(Q: Jun. 2021 )
=	Total Assets	-	Accounts Payable & Accrued Expense	-	Excess Cash
=	Total Assets	-	Accounts Payable & Accrued Expense	-	( Cash, Cash Equivalents, Marketable Securities	-	max(0, Total Current Liabilities	-	Total Current Assets	+	Cash, Cash Equivalents, Marketable Securities	))
=	12.929	-	1.569	-	( 0.262	-	max(0, 4.87	-	7.707	+	0.262	))
=	11.098

Note: The Operating Income data used here is two times the semi-annual (Jun. 2021) data.

2. Joel Greenblatt's definition of Return on Capital:

Biomedical Computer Technologies NyRt.'s annualized ROC (Joel Greenblatt) % for the quarter that ended in Jun. 2021 is calculated as:

	ROC (Joel Greenblatt) %		(Q: Jun. 2021 )
=	EBIT	/	Average of (Net fixed Assets	+	Net Working Capital)
=	EBIT	/	Average of (Property, Plant and Equipment	+	Net Working Capital)
			Q: Dec. 2020		Q: Jun. 2021
=	EBIT	/	( ( (Property, Plant and Equipment + Net Working Capital)	+	(Property, Plant and Equipment + Net Working Capital) )	/	count )
=	-1.412	/	( ( (2.545 + max(6.878, 0))	+	(2.507 + max(5.766, 0)) )	/	2 )
=	-1.412	/	( ( 9.423	+	8.273 )	/	2 )
=	-1.412	/	8.848
=	-15.96 %

where Working Capital is:

	Working Capital		(Q: Dec. 2020 )
=	(Accounts Receivable	+	Total Inventories	+	Other Current Assets)	-	(Accounts Payable & Accrued Expense	+	Defer. Rev.	+	Other Current Liabilities)
=	(2.085	+	1.184	+	6.637)	-	(2.871	+	0	+	0.157)
=	6.878

	Working Capital		(Q: Jun. 2021 )
=	(Accounts Receivable	+	Total Inventories	+	Other Current Assets)	-	(Accounts Payable & Accrued Expense	+	Defer. Rev.	+	Other Current Liabilities)
=	(1.403	+	1.191	+	4.851)	-	(1.569	+	0	+	0.11)
=	5.766

When net working capital is negative, 0 is used.

Note: The EBIT data used here is two times the semi-annual (Jun. 2021) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

Biomedical Computer Technologies NyRt.'s Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %	=	EBIT (TTM)	/	Enterprise Value (Q: Jun. 2021 )
	=	-1.385	/	5.607
	=	-24.70 %

Biomedical Computer Technologies NyRt. EBIT Related Terms

Thank you for viewing the detailed overview of Biomedical Computer Technologies NyRt.'s EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.

Biomedical Computer Technologies NyRt. (FRA:BCT) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Industrials » Industrial Products » Biomedical Computer Technologies NyRt. (FRA:BCT) » Definitions » EBIT

Comparable Companies

Traded in Other Exchanges

N/A

Address

Pasareti ut 83, Budapest, HUN, 1026

Website

https://www.setnyrt.com

SET GROUP Nyrt is engaged in developing & producing hydrogen storage solutions with industrial size and hydrogen based accumulators.

Biomedical Computer Technologies NyRt. (FRA:BCT) Headlines

No Headlines